Showing results (1051-1060 of 4,874) with videos related to

Sort By:
Pageof 488
Urologic Oncology|February 22, 2024
Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancerManuel Ozambela, Barrett Z McCormick, Jan K Rudzinski, et al.
Urologic Oncology|March 1, 2024
The role of neoadjuvant chemotherapy for patients with variant histology muscle invasive bladder cancer undergoing robotic cystectomy: Data from the International Robotic Cystectomy ConsortiumIan Cooke, Nassib Abou Heidar, Abdul Wasay Mahmood, et al.
Urologic Oncology|February 25, 2024
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancerNatalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, et al.
Urologic Oncology|February 14, 2024
Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equalMichael E Rezaee, Maximilian Pallauf, Sean A Fletcher, et al.
Urologic Oncology|March 20, 2024
The assessment of bladder cancer resectability with bimanual palpation: A prospective study in laparoscopy and open cystectomy patientsAnna K Czech, Katarzyna Gronostaj, Jakub Frydrych, et al.
Urologic Oncology|July 11, 2024
The impact of metabolic syndrome on short term radical cystectomy complicationsAaron S Dahmen, Alon Lazarovich, David J Nusbaum, et al.
Urologic Oncology|July 10, 2024
Clinical considerations for sexual and gender minorities with prostate cancerDaniel R Dickstein, Channa Amarasekera, Ronald C Chen, et al.
Urologic Oncology|July 3, 2024
Optimal imaging techniques across the spectrum of testicular cancerKshitij Pandit, Dhruv Puri, Kit Yuen, et al.
Urologic Oncology|April 3, 2024
Variation in management of lymph node positive prostate cancer after radical prostatectomy within a statewide quality improvement consortiumDaniel Triner, Stephanie Daignault-Newton, Udit Singhal, et al.
Urologic Oncology|January 25, 2024
Patient experience and unmet needs in high-risk nonmuscle-invasive bladder cancer: Insights from qualitative interviews and a cross-sectional surveyLewis Kopenhafer, Allison Thompson, Jane Chang, et al.
Pageof 488